For years, a protein inside our cells has quietly powered billions of dollars' worth of cancer drugs. Now a team of researchers have discovered that this workhorse protein, called cereblon, in ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...

Mouth cancer chemotherapy (chemo), targeted therapy, and immunotherapy are called systemic therapies. They travel through the bloodstream to treat mouth cancer cells anywhere in the body. Your care ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

In a mouse study, RNA micelles shrunk metastasized tumors in lungs. A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other ...

- First trial participant treated with PTM-101, an investigational thin film formulation of paclitaxel placed directly over the tumor for continuous localized drug exposure - - Trial enrolling ...

In late 2024, 73-year-old Mai Thi Vu began feeling chronically unwell. She was intensely fatigued and consistently nauseous. Her nails were turning black, she was rapidly losing weight and her skin ...

Fort Worth-based NanOlogy, LLC, a clinical-stage oncology company, has named veteran biopharma executive David Arthur as its new chief executive officer. Arthur becomes the company’s chief executive ...